{
    "organizations": [],
    "uuid": "7b2c29b17de80a80c86743a21ae6cf9d51b40fd3",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-zhejiang-hisun-pharmaceutical-rece/brief-zhejiang-hisun-pharmaceutical-receives-gmp-certificates-idUSL3N1SE3KL",
    "ord_in_thread": 0,
    "title": "Zhejiang Hisun Pharmaceutical receives GMP certificates",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 7 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd\n* Says it received goods manufacture practice (GMP) certificates from Zhejiang Food and Drug Administration\n* Certificate issued to crude drugs and antineoplastic drugs manufactured by the company and the valid period is until 2023\nSource text in Chinese: goo.gl/Zy4x5Q\n (Beijing Headline News)\nOur ",
    "published": "2018-05-07T18:23:00.000+03:00",
    "crawled": "2018-05-08T16:50:21.008+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "zhejiang",
        "hisun",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "received",
        "good",
        "manufacture",
        "practice",
        "gmp",
        "certificate",
        "zhejiang",
        "food",
        "drug",
        "administration",
        "certificate",
        "issued",
        "crude",
        "drug",
        "antineoplastic",
        "drug",
        "manufactured",
        "company",
        "valid",
        "period",
        "source",
        "text",
        "chinese",
        "beijing",
        "headline",
        "news"
    ]
}